Publicaciones en las que colabora con Mª Belén García Berrocal (10)

2016

  1. Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed with Bipolar Disorder

    Medicine (United States), Vol. 95, Núm. 6

2014

  1. Dose reduction of efavirenz: An observational study describing cost-effectiveness, pharmacokinetics and pharmacogenetics

    Pharmacogenomics, Vol. 15, Núm. 7, pp. 997-1006

2005

  1. Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients

    Clinica Chimica Acta, Vol. 354, Núm. 1-2, pp. 123-130

  2. Clinical evaluation of a microsphere bead-based flow cytometry assay for the simultaneous determination of anti-thyroid peroxidase and anti-thyroglobulin antibodies

    Clinical Biochemistry, Vol. 38, Núm. 11, pp. 966-972

  3. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients

    Clinica Chimica Acta, Vol. 359, Núm. 1-2, pp. 109-114

2004

  1. Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus

    Clinical Chemistry and Laboratory Medicine, Vol. 42, Núm. 3, pp. 266-272

  2. Clinical Evaluation of Cobas Core Anti-dsDNA EIA Quant

    Journal of Clinical Laboratory Analysis, Vol. 18, Núm. 3, pp. 200-205

  3. Partial Androgen Deficiency in Aging Type 2 Diabetic Men and Its Relationship to Glycemic Control

    Metabolism: Clinical and Experimental, Vol. 53, Núm. 5, pp. 666-672

1999

  1. Antiphosphatidylserine antibodies in patients with autoimmune diseases and HIV-infected patients: Effects of Tween 20 and relationship with antibodies to β2-glycoprotein I

    Journal of Clinical Laboratory Analysis, Vol. 13, Núm. 2, pp. 59-64

  2. Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers

    European Journal of Clinical Investigation, Vol. 29, Núm. 7, pp. 637-642